Identify a common signature to SAID enabling rapid differential diagnosis
Provide deep characterization of each specific pathogenic pathway and build dedicated analysis kits
Build a robust algorithm enabling reliable triage among the whole SAID spectrum
The coronavirus pandemic has brought to light a new autoinflammatory condition that affects children: the paediatric multisystem inflammatory syndrome (PIMS). Pr Alexandre Belot, paediatric rheumatologist, tells us more about the symptoms of this disease, the treatments and the protective effect of vaccination on this pathology.
IMMUNAID, The European project willing to identify biomarkers for the diagnosis of rare systemic autoinflammatory diseases, has just opened clinical sites in Belgium, Switzerland and in the UK, reaching more than half of the full recruitment capacity.
The NLRP3 inflammasome is the most thoroughly studied of the inflammasomes, and represents a valuable target in the clinical evaluation and treatment of systemic autoinflammatory diseases (SAIDs). We’ve summarised the rapidly progressing field of NLRP3 inflammasome regulation and its wider implications, both in the laboratory and in the clinic.
Page 1 of 2
Grant agreement no: 779295
Funded under: H2020-EU.3.1.1.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779295
The website does not collect any statistical and tracking data. Requests for information through the contact form ensures the protection of personal data by guaranteeing that data collection is carried out with the informed consent of individuals
